Asia Pacific Infertility Gonadotropins Market

研究執行與發布：Coherent Market Insights　·　發布日期 2026-05-07　·　155 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

2026 年市場規模: USD 1,198.2 Mn
2033 年預估規模: USD 2,917.6 Mn
年複合成長率 CAGR: 13.6%

以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。

出版商 Coherent Market Insights 產業別 Healthcare & Life Sciences出版日期 2026-05-07頁數 155報告編號 CMI9473

授權報價

Single User Price	$4,500 USD
Enterprise License	$10,000 USD

洽詢購買申請 Sample

完整報告名稱與涵蓋範圍

Asia Pacific Infertility Gonadotropins Market, By Type (Human Chorionic Gonadotropin, Follicle Stimulating Hormone, Menotropins, Others), By Product Type (Branded and Generics), By Route of Administration: (Intramuscular and Subcutaneous), By Application (Female Infertility and Male Infertility), By Type of Infertility (Primary Infertility, Secondary Infertility), By Age Group (1825, 2630, 3135, 36 and Above), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Government Supply / Public Health Programs), By Geography (Asia Pacific)

報告摘要

The Asia Pacific infertility gonadotropins market is estimated to be valued at USD 1,198.2 Mn in 2026 and is expected to reach USD 2,917.6 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 13.6% from 2026 to 2033. Infertility gonadotropins form an essential component segment of the region’s fast-growing assisted reproductive technology (ART) market owing to the increasing number of couples facing fertility issues in the region. Follicle-Stimulating Hormone (FSH), Luteinizing Hormone (LH), and chorionic gonadotropin are examples of gonadotropins that help in regulating the functions of the ovaries, which is useful during fertility treatments, particularly IVF. Recombinant forms of such medications are generally recommended as they offer high purity. There are several factors responsible for driving the growth rate of the market for infertility gonadotropins in the region. These factors include increased awareness about reproductive issues, delayed marriages, infertility due to unhealthy lifestyles, and improved acceptance rates regarding fertility treatments. In addition, some other factors are disposable incomes, urbanization, proliferation of fertility centers in tier-I and tier-II cities, and medical advancements. Market Dynamics The Asia Pacific infertility gonadotropins market is largely fueled by an increase in the number of infertility cases due to late parenthood, changes in lifestyle habits, and reproductive problems arising due to stress. Rising prevalence of assisted reproductive technology and reduced social taboos related to fertility have led to an increasing patient base. Also, the development of advanced technologies used in fertility treatments has played a key role in improving the success rates of IVF treatment. The market faces some restraints, such as high cost of treatment, minimal or no reimbursement for the cost, high costs involved for medium and lower middle-class patients, adherence to standards, storage issues, among others. The opportunities in this market can arise through expanded availability of fertility clinics in semi-urban locations, increased medical tourism, fertility preservation, biologics and biosimilar drugs, and telemedicine services. Key Features of the Study • This report provides in-depth analysis of the Asia Pacific infertility gonadotropins market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the Asia Pacific infertility gonadotropins market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies • Key companies covered as a part of this study include Merck KGaA, Ferring Pharmaceuticals, Organon & Co., IBSA Institut Biochimique SA, Bharat Serums and Vaccines Limited, Intas Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Zydus Lifesciences Ltd., Lupin Limited, and Dr. Reddy's Laboratories Ltd. • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The Asia Pacific infertility gonadotropins market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Asia Pacific infertility gonadotropins market Market Segmentation • Type Insights (Revenue, USD Mn, 2021 - 2033) o Human Chorionic Gonadotropin o Follicle Stimulating Hormone o Menotropins o Others • Product Type Insights (Revenue, USD Mn, 2021 - 2033) o Branded o Generics • Route of Administration Insights (Revenue, USD Mn, 2021 - 2033) o Intramuscular o Subcutaneous • Application Insights (Revenue, USD Mn, 2021 - 2033) o Female Infertility o Male Infertility • Type of Infertility Insights (Revenue, USD Mn, 2021 - 2033) o Primary Infertility o Secondary Infertility • Age Group Insights (Revenue, USD Mn, 2021 - 2033) o 18–25 o 26–30 o 31–35 o 36 and Above • Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033) o Hospital Pharmacies o Retail Pharmacies o Online Pharmacies o Government Supply / Public Health Programs • Country Insights (Revenue, USD Mn, 2021 - 2033) o Japan o China o ASEAN o India o Australia o Rest of Asia Pacific • Key Players Insights o Merck KGaA o Ferring Pharmaceuticals o Organon & Co. o IBSA Institut Biochimique SA o Bharat Serums and Vaccines Limited o Intas Pharmaceuticals Ltd. o Sun Pharmaceutical Industries Ltd. o Zydus Lifesciences Ltd. o Lupin Limited o Reddy's Laboratories Ltd.

目錄 Table of Contents

Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Asia Pacific Infertility Gonadotropins Market, By Type  Asia Pacific Infertility Gonadotropins Market, By Product Type  Asia Pacific Infertility Gonadotropins Market, By Route of Administration  Asia Pacific Infertility Gonadotropins Market, By Application  Asia Pacific Infertility Gonadotropins Market, By Type of Infertility  Asia Pacific Infertility Gonadotropins Market, By Age Group  Asia Pacific Infertility Gonadotropins Market, By Distribution Channel  Asia Pacific Infertility Gonadotropins Market, By Country 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics o Impact Analysis o Key Highlights o Regulatory Scenario o Product Launches/Approvals o PEST Analysis o PORTER’s Analysis o Market Opportunities o Regulatory Scenario o Key Developments o Industry Trends 4. Asia Pacific Infertility Gonadotropins Market, By Type, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Human Chorionic Gonadotropin  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Follicle Stimulating Hormone  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Menotropins  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 5. Asia Pacific Infertility Gonadotropins Market, By Product Type, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Branded  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Generics  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 6. Asia Pacific Infertility Gonadotropins Market, By Route of Administration, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Intramuscular  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Subcutaneous  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 7. Asia Pacific Infertility Gonadotropins Market, By Application, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Female Infertility  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Male Infertility  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 8. Asia Pacific Infertility Gonadotropins Market, By Type of Infertility, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Primary Infertility  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Secondary Infertility  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 9. Asia Pacific Infertility Gonadotropins Market, By Age Group, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o 18-25  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o 26-30  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o 31-35  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o 36 and Above  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 10. Asia Pacific Infertility Gonadotropins Market, By Distribution Channel, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Hospital Pharmacies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Retail Pharmacies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Online Pharmacies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Government Supply / Public Health Programs  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 11. Asia Pacific Infertility Gonadotropins Market, By Country, 2021 - 2033, Value (USD Mn) o Introduction  Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)  Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)  Country Trends o Japan  Introduction  Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, Route of Administration, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, Type of Infertility, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, Age Group, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, Distribution Channel, 2021 - 2033, Value (USD Mn) o China  Introduction  Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, Route of Administration, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, Type of Infertility, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, Age Group, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, Distribution Channel, 2021 - 2033, Value (USD Mn) o ASEAN  Introduction  Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, Route of Administration, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, Type of Infertility, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, Age Group, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, Distribution Channel, 2021 - 2033, Value (USD Mn) o India  Introduction  Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, Route of Administration, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, Type of Infertility, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, Age Group, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, Distribution Channel, 2021 - 2033, Value (USD Mn) o Australia  Introduction  Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, Route of Administration, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, Type of Infertility, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, Age Group, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, Distribution Channel, 2021 - 2033, Value (USD Mn) o Rest of Asia Pacific  Introduction  Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, Route of Administration, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, Type of Infertility, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, Age Group, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, Distribution Channel, 2021 - 2033, Value (USD Mn) 12. Competitive Landscape o Merck KGaA  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Ferring Pharmaceuticals  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Organon & Co.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o IBSA Institut Biochimique SA  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Bharat Serums and Vaccines Limited  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Intas Pharmaceuticals Ltd.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Sun Pharmaceutical Industries Ltd.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Zydus Lifesciences Ltd.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Lupin Limited  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Reddy's Laboratories Ltd.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies 13. Analyst Recommendations o Wheel of Fortune o Analyst View o Coherent Opportunity Map 14. References and Research Methodology o References o Research Methodology o About us *Browse 32 market data tables and 28 figures on Infertility Gonadotropins Market – Asia Pacific forecast to 2033

提及公司

Merck KGaAFerring PharmaceuticalsOrganon & Co.IBSA Institut Biochimique SABharat Serums and Vaccines LimitedIntas Pharmaceuticals Ltd.Sun Pharmaceutical Industries Ltd.Zydus Lifesciences Ltd.Lupin LimitedReddy's Laboratories Ltd.

同分類最新報告（醫療與生命科學）

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們